Cargando…

Zinc transporter 8 autoantibodies complement glutamic acid decarboxylase and insulinoma‐associated antigen‐2 autoantibodies in the identification and characterization of Japanese type 1 diabetes

AIMS/INTRODUCTION: This study aimed to investigate the significance of zinc transporter 8 autoantibody (ZnT8A) in identifying and characterizing autoimmune‐mediated type 1 diabetes in Japanese individuals. METHODS: ZnT8A were determined in 324 patients with type 1 diabetes, 191 phenotypic type 2 dia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawasaki, Eiji, Oikawa, Yoichi, Okada, Akira, Kanatsuna, Norio, Kawamura, Tomoyuki, Kikuchi, Tadashi, Terasaki, Jungo, Miura, Junnosuke, Ito, Yoshihisa, Hanafusa, Toshiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477512/ https://www.ncbi.nlm.nih.gov/pubmed/32175683 http://dx.doi.org/10.1111/jdi.13251

Ejemplares similares

Different interaction of onset age and duration of type 1 diabetes on the dynamics of autoantibodies to insulinoma‐associated antigen‐2 and zinc transporter 8
por: Kawasaki, Eiji, et al.
Publicado: (2020)

Comparing the clinical significance and antigen specificity of insulinoma‐associated antigen‐2 autoantibodies between radioimmunoassay and enzyme‐linked immunosorbent assay in Japanese patients with type 1 diabetes
por: Kawasaki, Eiji, et al.
Publicado: (2022)

Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan
por: Yasui, Junichi, et al.
Publicado: (2016)

Bivalent GAD autoantibody ELISA improves clinical utility and risk prediction for adult autoimmune diabetes
por: Kawasaki, Eiji, et al.
Publicado: (2023)

Discrepancy of glutamic acid decarboxylase 65 autoantibody results between RSR radioimmunoassay and enzyme‐linked immunosorbent assay in patients with type 1 diabetes is related to autoantibody affinity
por: Kawasaki, Eiji, et al.
Publicado: (2019)

Pathogenic Roles of Glutamic Acid Decarboxylase 65 Autoantibodies in Cerebellar Ataxias
por: Mitoma, Hiroshi, et al.
Publicado: (2017)

Clinical heterogeneity of adult Japanese diabetes depending on titers of glutamic acid decarboxylase autoantibodies
por: Aoyama, Tomohisa, et al.
Publicado: (2012)

Characterization of patients with diabetes who were incidentally found to be glutamic acid decarboxylase autoantibody‐positive by bridging‐type enzyme‐linked immunosorbent assay
por: Kawasaki, Eiji, et al.
Publicado: (2020)

α Cell dysfunction in islets from nondiabetic, glutamic acid decarboxylase autoantibody–positive individuals
por: Doliba, Nicolai M., et al.
Publicado: (2022)

Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome
Publicado: (1993)

A Rare Case of Cerebellar Ataxia Due to Voltage-Gated Calcium Channel and Glutamic Acid Decarboxylase Autoantibodies
por: Annunziata, Giuseppe, et al.
Publicado: (2017)

Prevalence of diabetes and presence of autoantibodies against zinc transporter 8 and glutamic decarboxylase at diagnosis and at follow up of Graves’ disease
por: Jonsdottir, Berglind, et al.
Publicado: (2019)

Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function
por: Zhu, Yuxiao, et al.
Publicado: (2020)

Anti-Islet Autoantibodies in Type 1 Diabetes
por: Kawasaki, Eiji
Publicado: (2023)

Detection of autoantibodies against reactive oxygen species modified glutamic acid decarboxylase-65 in type 1 diabetes associated complications
por: Khan, Mohd Wajid Ali, et al.
Publicado: (2011)

Glutamic Acid Decarboxylase Autoantibody-negative Slowly Progressive Type 1 Diabetes Mellitus: A Case Report and Literature Review
por: Kobayashi, Michi, et al.
Publicado: (2018)

Increased diagnosis of autoimmune childhood‐onset Japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme‐linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit
por: Sugihara, Shigetaka, et al.
Publicado: (2019)

Factor H Autoantibodies and Complement-Mediated Diseases
por: Zhang, Yuzhou, et al.
Publicado: (2020)

A New Luminescence Assay for Autoantibodies to Mammalian Cell–Prepared Insulinoma-Associated Protein 2
por: Burbelo, Peter D., et al.
Publicado: (2008)

Endogenous insulin secretion even at a very low level contributes to the stability of blood glucose control in fulminant type 1 diabetes
por: Shibasaki, Saeko, et al.
Publicado: (2010)

Autoantibodies against complement factor B in rheumatoid arthritis
por: Matola, Alexandra T., et al.
Publicado: (2023)

Danish children born with glutamic acid decarboxylase-65 and islet antigen-2 autoantibodies at birth had an increased risk to develop type 1 diabetes
por: Eising, Stefanie, et al.
Publicado: (2011)

Class II HLA genotype in fulminant type 1 diabetes: A nationwide survey with reference to glutamic acid decarboxylase antibodies
por: Tsutsumi, Chiharu, et al.
Publicado: (2011)

Glutamic acid decarboxylase autoantibodies are dominant but insufficient to identify most Chinese with adult-onset non-insulin requiring autoimmune diabetes: LADA China study 5
por: Xiang, Yufei, et al.
Publicado: (2015)

Clinical and genetic characteristics of people with type 1 diabetes who have discrepancies in titers of anti‐glutamic acid decarboxylase antibody measured by radioimmunoassay and enzyme‐linked immunosorbent assay
por: Takagi, Satoshi, et al.
Publicado: (2019)

MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity
por: Yandamuri, Soumya S., et al.
Publicado: (2023)

Sequence homology of the diabetes-associated autoantigen glutamate decarboxylase with coxsackie B4-2C protein and heat shock protein 60 mediates no molecular mimicry of autoantibodies
Publicado: (1994)

Deficiency of complement factor H-related proteins and autoantibody-positive hemolytic uremic syndrome in an infant with combined partial deficiencies and autoantibodies to complement factor H and ADAMTS13
por: Michael, Mini, et al.
Publicado: (2018)

Deficiency of complement factor H-related proteins and autoantibody-positive hemolytic uremic syndrome in an infant with combined partial deficiencies and autoantibodies to complement factor H and ADAMTS13
por: Michael, Mini, et al.
Publicado: (2018)

Possible Contribution of Taurine to Distorted Glucagon Secretion in Intra-Islet Insulin Deficiency: A Metabolome Analysis Using a Novel α-Cell Model of Insulin-Deficient Diabetes
por: Bessho, Megumi, et al.
Publicado: (2014)

Myasthenia gravis complement activity is independent of autoantibody titer and disease severity
por: Fichtner, Miriam L., et al.
Publicado: (2022)

Complement-dependent cytotoxicity of human autoantibodies against myelin oligodendrocyte glycoprotein
por: Kohyama, Kuniko, et al.
Publicado: (2023)

No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors
por: Hopfner, Franziska, et al.
Publicado: (2019)

Significance of Autoantibodies in Autoimmune Encephalitis in Relation to Antigen Localization: An Outline of Frequently Reported Autoantibodies with a Non-Systematic Review
por: Tanaka, Keiko, et al.
Publicado: (2020)

Autoantibodies in osteoarthritis
por: Menard, J, et al.
Publicado: (2003)

Autoantibodies in vasculitis
por: Wiik, Allan
Publicado: (2003)

Editorial: Autoantibodies
por: Holmdahl, Rikard, et al.
Publicado: (2019)

RETINAL AUTOANTIBODIES
por: JIRAWUTHIWORAVONG, GUY V., et al.
Publicado: (2007)

Complement-Activating Capacity of Autoantibodies Correlates With Disease Activity in Bullous Pemphigoid Patients
por: Chiorean, Roxana M., et al.
Publicado: (2018)

Autoantibodies against complement component C1q in systemic lupus erythematosus
por: Trendelenburg, Marten
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9l1dcjme7tnte21hdgqk6ag2rs